569 related articles for article (PubMed ID: 26310586)
21. Types of progestogens in combined oral contraception: effectiveness and side-effects.
Lawrie TA; Helmerhorst FM; Maitra NK; Kulier R; Bloemenkamp K; Gülmezoglu AM
Cochrane Database Syst Rev; 2011 May; (5):CD004861. PubMed ID: 21563141
[TBL] [Abstract][Full Text] [Related]
22. Progestin-only pills for contraception.
Grimes DA; Lopez LM; O'Brien PA; Raymond EG
Cochrane Database Syst Rev; 2010 Jan; (1):CD007541. PubMed ID: 20091638
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of oral contraceptives and cardiovascular disease.
Chasan-Taber L; Stampfer MJ
Ann Intern Med; 1998 Mar; 128(6):467-77. PubMed ID: 9499331
[TBL] [Abstract][Full Text] [Related]
24. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.
Dragoman MV; Tepper NK; Fu R; Curtis KM; Chou R; Gaffield ME
Int J Gynaecol Obstet; 2018 Jun; 141(3):287-294. PubMed ID: 29388678
[TBL] [Abstract][Full Text] [Related]
25. Combined oral contraceptives: risks and benefits.
Thorogood M; Villard-Mackintosh L
Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
[TBL] [Abstract][Full Text] [Related]
26. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis.
Zimmerman Y; Eijkemans MJ; Coelingh Bennink HJ; Blankenstein MA; Fauser BC
Hum Reprod Update; 2014; 20(1):76-105. PubMed ID: 24082040
[TBL] [Abstract][Full Text] [Related]
27. Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies.
Xu Z; Li Y; Tang S; Huang X; Chen T
Thromb Res; 2015 Jul; 136(1):52-60. PubMed ID: 25936231
[TBL] [Abstract][Full Text] [Related]
28. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
30. The combined oral contraceptive. Risks and adverse effects in perspective.
Bagshaw S
Drug Saf; 1995 Feb; 12(2):91-6. PubMed ID: 7766340
[TBL] [Abstract][Full Text] [Related]
31. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
32. Skin patch and vaginal ring versus combined oral contraceptives for contraception.
Lopez LM; Grimes DA; Gallo MF; Stockton LL; Schulz KF
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD003552. PubMed ID: 23633314
[TBL] [Abstract][Full Text] [Related]
33. Modern oral contraceptives and cardiovascular disease.
Rosenberg L; Palmer JR; Sands MI; Grimes D; Bergman U; Daling J; Mills A
Am J Obstet Gynecol; 1997 Sep; 177(3):707-15. PubMed ID: 9322646
[TBL] [Abstract][Full Text] [Related]
34. Combined oral contraceptive pills for treatment of acne.
Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
Cochrane Database Syst Rev; 2012 Jul; (7):CD004425. PubMed ID: 22786490
[TBL] [Abstract][Full Text] [Related]
35. Combined oral contraceptive pills for treatment of acne.
Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
Cochrane Database Syst Rev; 2012 Jun; (6):CD004425. PubMed ID: 22696343
[TBL] [Abstract][Full Text] [Related]
36. Combined hormonal contraceptive use among breastfeeding women: an updated systematic review.
Tepper NK; Phillips SJ; Kapp N; Gaffield ME; Curtis KM
Contraception; 2016 Sep; 94(3):262-74. PubMed ID: 26002804
[TBL] [Abstract][Full Text] [Related]
37. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins Long S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009849. PubMed ID: 26195091
[TBL] [Abstract][Full Text] [Related]
38. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.
Fitzpatrick D; Pirie K; Reeves G; Green J; Beral V
PLoS Med; 2023 Mar; 20(3):e1004188. PubMed ID: 36943819
[TBL] [Abstract][Full Text] [Related]
39. Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.
Lalude OO
Curr Cardiol Rep; 2013 Jul; 15(7):374. PubMed ID: 23715878
[TBL] [Abstract][Full Text] [Related]
40. The risk of arterial thrombosis increases with the use of combined oral contraceptives.
Lidegaard Ø
Evid Based Med; 2016 Feb; 21(1):38. PubMed ID: 26574484
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
